Bradley Leonard Ormsby Acquires 3 Shares of Judges Scientific (LON:JDG) Stock

Judges Scientific plc (LON:JDG) insider Bradley Leonard Ormsby bought 3 shares of the business’s stock in a transaction dated Monday, January 5th. The shares were bought at an average cost of GBX 5,753 per share, for a total transaction of £172.59.

Bradley Leonard Ormsby also recently made the following trade(s):

• On Friday, December 5th, Bradley Leonard Ormsby purchased 2 shares of Judges Scientific stock. The stock was bought at an average price of GBX 5,985 per share, with a total value of £119.70.

Judges Scientific Trading Down 0.3%

Shares of JDG opened at GBX 5,700 on Friday. The business’s 50-day moving average price is GBX 5,467.10 and its 200 day moving average price is GBX 6,284.70. The company has a current ratio of 1.97, a quick ratio of 0.65 and a debt-to-equity ratio of 70.79. The stock has a market capitalization of £379.11 million, a P/E ratio of 34.97, a P/E/G ratio of 0.56 and a beta of 0.83. Judges Scientific plc has a 1-year low of GBX 4,400 and a 1-year high of GBX 9,120.

Judges Scientific News Summary

Here are the key news stories impacting Judges Scientific this week:

• Positive Sentiment: Multiple insiders (including David Cicurel, Bradley Ormsby, Tim Prestidge and Ian Wilcock) purchased small lots (3 shares each) at ~GBX 5,753 on Jan 5 — a signal of insider confidence but immaterial in size. MarketBeat Insider Trades
• Positive Sentiment: Brokers have reaffirmed constructive ratings (Jefferies and Berenberg reiterating buys with targets ~GBX 7,380–7,900; consensus target ~GBX 7,640), which supports upside vs. the current price. MarketBeat Analyst Notes
• Neutral Sentiment: Judges remains an acquisitive group focused on niche scientific-instrument businesses (23 subsidiaries) — a steady, long-term strategy but one that can make near-term performance dependent on acquisition timing and integration. Company Profile
• Negative Sentiment: Balance-sheet and liquidity metrics may worry investors: a high debt-to-equity (~70.8%) and a quick ratio below 1 (0.65) increase sensitivity to earnings volatility. Financial Metrics
• Negative Sentiment: Technical weakness: the share price sits below the 200‑day moving average (GBX 6,308) and near the 50‑day, which can prompt tactical selling; intraday volume above average suggests higher selling pressure today. Price & Volume Data

Analyst Upgrades and Downgrades

Several analysts have recently commented on JDG shares. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 7,380 target price on shares of Judges Scientific in a research report on Tuesday, November 4th. Berenberg Bank restated a “buy” rating and set a GBX 7,900 price objective on shares of Judges Scientific in a research report on Wednesday, November 26th. Finally, Shore Capital reaffirmed a “house stock” rating on shares of Judges Scientific in a research note on Thursday, September 18th. Two investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, Judges Scientific currently has an average rating of “Buy” and an average target price of GBX 7,640.

Judges Scientific Company Profile

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 23 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen’s Awards for innovation and export.

The Group’s companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash.